KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Opko Health (OPK) Equity Income (2016 - 2026)

Opko Health filings provide 15 years of Equity Income readings, the most recent being -$2000.0 for Q1 2026.

  • On a quarterly basis, Equity Income rose 77.78% to -$2000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$22000.0, a 37.5% decrease, with the full-year FY2025 number at -$29000.0, down 61.11% from a year prior.
  • Equity Income hit -$2000.0 in Q1 2026 for Opko Health, up from -$17000.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of -$1000.0 in Q2 2024 to a low of -$268000.0 in Q2 2022.
  • Median Equity Income over the past 5 years was -$17000.0 (2025), compared with a mean of -$35266.7.
  • Biggest five-year swings in Equity Income: plummeted 300.0% in 2022 and later surged 97.62% in 2024.
  • Opko Health's Equity Income stood at -$24000.0 in 2022, then surged by 66.67% to -$8000.0 in 2023, then soared by 62.5% to -$3000.0 in 2024, then plummeted by 466.67% to -$17000.0 in 2025, then soared by 88.24% to -$2000.0 in 2026.
  • The last three reported values for Equity Income were -$2000.0 (Q1 2026), -$17000.0 (Q4 2025), and -$3000.0 (Q3 2025) per Business Quant data.